Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study.
Int J Cancer. 2024 Jul 1;155(1):128-138. doi: 10.1002/ijc.34912. Epub 2024 Mar 6.
Int J Cancer. 2024.
PMID: 38447007
Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer.
Fasching PA, Decker T, Hartkopf A, Nusch A, Heinrich BJ, Kurbacher C, Fuchs R, Tesch H, Krabisch P, Huober J, Kuemmel S, Brucker S, Janni W, Schneeweiss A, Schuler M, Fehm T, Lüftner D, Quiering C, Voges C, Kreuzeder J, Reinisch M.
Fasching PA, et al. Among authors: kreuzeder j.
Eur J Cancer. 2024 Feb;198:113480. doi: 10.1016/j.ejca.2023.113480. Epub 2023 Dec 15.
Eur J Cancer. 2024.
PMID: 38154393
Free article.
Clinical Trial.
Item in Clipboard
The Endocrine Treatment Landscape for Patients with HR+ HER2- Early-stage Breast Cancer in Germany Before the Introduction of CDK4/6 Inhibitor Therapy - A Real-World Analysis.
Nabieva N, Altmann F, Apel K, Baerens DT, Beha M, Belau A, Busch S, Guth D, Heinrich G, Kreiss-Sender J, Markmann S, Olbermann A, Oskay-Özcelik G, Schuback B, Steinfeld-Birg D, Quiering C, Kiss F, Kreuzeder J, Nuti P, Schilling J.
Nabieva N, et al. Among authors: kreuzeder j.
Geburtshilfe Frauenheilkd. 2023 Jul 18;83(9):1127-1137. doi: 10.1055/a-2100-0643. eCollection 2023 Sep.
Geburtshilfe Frauenheilkd. 2023.
PMID: 37942358
Free PMC article.
Item in Clipboard
Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer - Controversies and Standards in Healthcare.
Müller V, Fasching PA, Nabieva N, Fehm TN, Thill M, Schmidt M, Kühn T, Banys-Paluchowski M, Belleville E, Juhasz-Böss I, Untch M, Kolberg HC, Harbeck N, Aktas B, Stickeler E, Kreuzeder J, Hartkopf AD, Janni W, Ditsch N.
Müller V, et al. Among authors: kreuzeder j.
Geburtshilfe Frauenheilkd. 2023 May 23;83(6):673-685. doi: 10.1055/a-2073-1887. eCollection 2023 Jun.
Geburtshilfe Frauenheilkd. 2023.
PMID: 37614683
Free PMC article.
Item in Clipboard
The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial.
Hadji P, Stoetzer O, Decker T, Kurbacher CM, Marmé F, Schneeweiss A, Mundhenke C, Distelrath A, Fasching PA, Lux MP, Lüftner D, Janni W, Muth M, Kreuzeder J, Quiering C, Grischke EM, Tesch H.
Hadji P, et al. Among authors: kreuzeder j.
J Bone Oncol. 2018 Oct 2;14:010-10. doi: 10.1016/j.jbo.2018.09.010. eCollection 2019 Feb.
J Bone Oncol. 2018.
PMID: 30515367
Free PMC article.
Item in Clipboard
Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial.
Tesch H, Stoetzer O, Decker T, Kurbacher CM, Marmé F, Schneeweiss A, Mundhenke C, Distelrath A, Fasching PA, Lux MP, Lüftner D, Hadji P, Janni W, Muth M, Kreuzeder J, Quiering C, Taran FA.
Tesch H, et al. Among authors: kreuzeder j.
Int J Cancer. 2019 Feb 15;144(4):877-885. doi: 10.1002/ijc.31738. Epub 2018 Oct 30.
Int J Cancer. 2019.
PMID: 29992557
Free PMC article.
Clinical Trial.
Item in Clipboard
Two-dimensional gel electrophoresis-based proteomics of mycobacteria.
Mattow J, Siejak F, Hagens K, Kreuzeder J, Kaufmann SH, Schaible UE.
Mattow J, et al. Among authors: kreuzeder j.
Methods Mol Biol. 2009;465:111-42. doi: 10.1007/978-1-59745-207-6_8.
Methods Mol Biol. 2009.
PMID: 20560054
Item in Clipboard
Cite
Cite